Skip to search formSkip to main contentSkip to account menu

CB-01-05-MMX

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

parnaparin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
CB-01-05-MMX, a novel oral controlled-release low molecular weight heparin for the potential treatment of ulcerative colitis.
CB-01-05-MMX (LMW Heparin MMX), being developed by Cosmo Pharmaceuticals SpA, is a novel oral parnaparin sodium formulation for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)